Hydroxy Chloroquine and Covid in RA Patients

NCT04471649 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2020-09-09

No results posted yet for this study

Summary

evaluation of the clinical course of COVID-19 in a cohort of patients with rheumatoid arthritis treated with or without hydroxychloroquine.

Conditions

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • Asem Elfert, Prof · tanta university faculty of medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-15
Primary Completion
2020-10-31
Completion
2020-11-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04471649 on ClinicalTrials.gov